Skip to main content

Advertisement

SpringerLink
Log in

Opioid resistance in chronic daily headache: A synthesis of ideas from the bench and bedside

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Chronic daily headache is a complex pain disorder that encompasses many diagnostic and therapeutic challenges. Our understanding of the pathophysiologic processes of intermittent migraine has improved over the past decade, but the biologic basis of chronic daily headache remains obscure. Some of the more common issues confounding management of patients who experience chronic daily headache are medication overuse, psychiatric comorbidity, refractoriness to pharmacologic treatments, and disability. Longacting opioid analgesics would appear to provide a viable treatment option for those patients who remain refractory to other treatment interventions; however, clinical experience often does not support this belief. Current concepts of the pathophysiologic basis of chronic pain and associated neural plasticity may elucidate a biologic basis for the general inefficacy of opioids in the management of chronic daily headache. This article explores the models of pathophysiology for migraine and chronic daily headache, the concept of chronic daily headache as a neuropathic pain syndrome, neural plasticity in the context of neuropathic pain states, the physiologic basis for opioid tolerance and opioid-induced hyperalgesia, and how each of these conditions interact to provoke the general lack of opioid efficacy often observed in the management of chronic daily headache.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Scher AI, Stewart WF, Liberman J, et al.: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.

    Article  PubMed  CAS  Google Scholar 

  2. Linton-Dahlof P, Linde M, Dahlof C: Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000, 20:658–662.

    Article  PubMed  CAS  Google Scholar 

  3. Fritsche G, Eberl A, Katasarava Z, et al.: Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001, 45:229–235.

    Article  PubMed  CAS  Google Scholar 

  4. Pini LA, Cicero AF, Sandrini M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001, 21:878–883.

    Article  PubMed  CAS  Google Scholar 

  5. Saper JR: From the role of chronic opioid therapy in managing chronic daily headache: a roundtable discussion. Presented at the Annual Scientific Meeting of the American Headache Society. Seattle, WA; 2002.

  6. Rothrock J. From The role of chronic opioid therapy in managing chronic daily headache: a roundtable discussion. Presented at the Annual Scientific Meeting of the American Headache Society. Seattle, WA; 2002.

  7. Zimmermann M: Pathobiology of neuropathic pain. Eur J Pharmacol 2001, 429:23–37.

    Article  PubMed  CAS  Google Scholar 

  8. Silberstein SD, Lipton RB, Sliwinski M: Classification of daily or near-daily headaches: a field study of the revised IHS criteria. Neurology 1996, 47:871–875.

    PubMed  CAS  Google Scholar 

  9. Silberstein SD, Lipton RB, Solomon S, et al.: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994, 34:1–7.

    Article  Google Scholar 

  10. Olesen J: Revision of the International Headache Classification: an interim report. Cephalalgia 2001, 21:261.

    Article  Google Scholar 

  11. Mathew NT, Stubits E, Nigam M: Transformation of migraine into daily headache: analysis of factors. Headache 1982, 22:66–68.

    Article  PubMed  CAS  Google Scholar 

  12. Vingen JV, Sand T, Stover LJ: Sensitivity to various stimuli in primary headaches: a questionnaire study. Headache 1999, 39:552–558.

    Article  PubMed  CAS  Google Scholar 

  13. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular analgesic use? [Abstract]. Cephalalgia 2000, 20:294.

    Google Scholar 

  14. Lance F, Parkes C, Wilkinson M: Does analgesic abuse cause headache de novo? Headache 1988, 38:61–62.

    Article  Google Scholar 

  15. Wilkinson SM, Becker WJ, Heine JA: Opiate use to control bowel motility may induce chronic headache in patients with migraine. Headache 2001, 41:303–309.

    Article  PubMed  CAS  Google Scholar 

  16. Rapoport AM, Stang P, Gutterman DL, et al.: Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996, 36:14–19.

    Article  PubMed  CAS  Google Scholar 

  17. Rapoport AM: Analgesic rebound headache. Headache 1988, 28:662–665.

    Article  PubMed  CAS  Google Scholar 

  18. Solomon S, Lipton RB, Newman LC: Clinical features of chronic daily headache. Headache 1992, 32:325–329.

    Article  PubMed  CAS  Google Scholar 

  19. Scher A, Stewart WF, Liberman J, et al.: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.

    Article  PubMed  CAS  Google Scholar 

  20. Castillo J, Munoz P, Guitera V, et al.: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196.

    Article  PubMed  CAS  Google Scholar 

  21. Granella F, Farina S, Malferrani G, et al.: Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987, 7:15–19.

    Article  PubMed  CAS  Google Scholar 

  22. Ravishankar K: Headache pattern in India-a headache clinic analysis of 1000 patients [abstract]. Cephalalgia 1997, 17:316–317.

    Google Scholar 

  23. Diener HC, Dahlof CGH: Headache associated with chronic use of substances. In The Headaches, edn 2. Edited by Olesen J, Tfelt-Hansen P, Welsh KMA. Philadelphia: Lippincott Williams & Wilkins; 2000:871–878.

    Google Scholar 

  24. Baumgartner C, Wessely P, Bingol C, et al.: Long-term prognosis of analgesic withdrawal in patients with drug-induced headache. Headache 1989, 29:510–514.

    Article  PubMed  CAS  Google Scholar 

  25. Schneider P, Aull S, Baumgartner C, et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 1996, 16:481–485.

    Article  Google Scholar 

  26. Diener HC, Dichgans J, Scholz E, et al.: Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989, 236:9–14.

    Article  PubMed  CAS  Google Scholar 

  27. Zed PJ, Loewen PS, Robinson G: Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 1999, 33:61–72.

    Article  PubMed  CAS  Google Scholar 

  28. Tepper SJ, Dodick DW: Debate: analgesic overuse is a cause, not consequence of chronic daily headache. Headache 2002, 42:543–554. This is an interesting dialogue and debate exploring the controversy surrounding the concept of medication-induced rebound headache in patients who experience chronic daily headache. Good arguments are given for each viewpoint.

    Article  PubMed  Google Scholar 

  29. Williamson DJ, Hargreaves RJ: Neurogenic inflammation in the context of migraine. Microsc Res Tech 2001, 53:167–178.

    Article  PubMed  CAS  Google Scholar 

  30. Aurora SK: Pathophysiology of migraine headache. Curr Pain Headache Rep 2001, 5:179–182.

    Article  PubMed  CAS  Google Scholar 

  31. Edvisson L: Pathophysiology of primary headaches. Curr Pain Headache Rep 2001, 5:71–78.

    Google Scholar 

  32. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614–624.

    Article  PubMed  CAS  Google Scholar 

  33. Burstein R, Cutrer FM, Yarnitsky D: The development of cutaneous allodynia during a migraine attack: clinical evidence for sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000, 123:1703–1709. The findings of this study have shed new light on the possible pathophysiologic processes and consequences of migraine, and piloted new opportunities for clinical investigation and basic science research in the field of headache.

    Article  PubMed  Google Scholar 

  34. Silberstein SD: Tension-type headache and chronic daily headache. Neurology 1993, 43:1644–1649.

    PubMed  CAS  Google Scholar 

  35. Welsh KMA, Goadsby PJ: Chronic daily headache. Curr Opin Neurol 2002, 15:287–295. This is a helpful review and synthesis of ideas related to chronic daily headache from two thought-leaders in the field of headache management and research. This is only one paper of a set of works devoted to the topic of chronic daily headache found in this journal issue.

    Article  Google Scholar 

  36. Sandrini G, Antonaci F, Pucci E: Comparative study with EMG, pressure algometry, and manual palpation in tension-type headache and migraine. Cephalalgia 1994, 14:451–457.

    Article  PubMed  CAS  Google Scholar 

  37. Jensen R, Olesen J: Initiating mechanisms of experimentally induced tension-type headache. Cephalalgia 1996, 16:175–182.

    Article  PubMed  CAS  Google Scholar 

  38. Bendtsen L, Ashina M: Sensitization of myofascial pain pathways in tension-type headache. In The Headaches, edn 2. Edited by Oleson J, Tfelt-Hansen P, Welsh KMA. Philadelphia: Lippincott Williams & Wilkins; 2000:573–577.

    Google Scholar 

  39. Moskowitz MA: The neurobiology of vascular head pain. Ann Neurol 1984, 15:157–168.

    Article  Google Scholar 

  40. Srikiatkhachorn A: Pathophysiology of chronic daily headache. Curr Pain Headache Rep 2001, 5:537–544. This is an understandable synthesis of concepts modeling the hypothesized pathophysiologic basis of chronic daily headache.

    PubMed  CAS  Google Scholar 

  41. Ji RR, Woolf CJ: Neuronal plasticity and spinal transduction in nociceptive neurons: implication for the initiation and maintenance of pathologic pain. Neurobiol Dis 2001, 8:1–10.

    Article  PubMed  CAS  Google Scholar 

  42. Clifford DB, Zorumski CF, Olney JW: Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures. Exp Neurol 1989, 105:272–279.

    Article  PubMed  CAS  Google Scholar 

  43. Grewal SS, York RD, Stork PJS: Extracellular-signal-regulated kinase signaling in neurons. Curr Opin Neurol 1999, 9:544–553.

    Article  CAS  Google Scholar 

  44. Ahlemeyer B, Kolker S, Zhu Y, et al.: Increase in glutamateinduced neurotoxicity by activated astrocytes involves stimulation of protein kinase C. J Neurochem 2002, 82:504–515.

    Article  PubMed  CAS  Google Scholar 

  45. Cardell M, Wieloch T: Time course of the translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat. J Neurochem 1993, 61:1308–1314.

    Article  PubMed  CAS  Google Scholar 

  46. Strubos PJLM: Nitric oxide in cerebral ischemia, neurodegeneration and excitotoxicity. Crit Rev Neurobiol 1998, 12:223–243.

    Google Scholar 

  47. Urushitani M, Shimohama S: The role of nitric oxide in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:71–81.

    Article  PubMed  CAS  Google Scholar 

  48. Ashina M, Bendtsen L, Jensen R, et al.: Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000, 123:1830–1837.

    Article  PubMed  Google Scholar 

  49. Welsh KMA, Nagesh V, Aurora S, et al.: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001, 41:629–637. This is an important paper that presents the prospect that migraine may cause neurotoxicity and neuronal injury that provokes the progression of intermittent migraine to a chronic, refractory pain disorder.

    Article  Google Scholar 

  50. Gutstein HB, Akil H: Opioid analgesics. In Goodman and Gilman’s: The Pharmacologic Basis of Therapeutics, edn 10. Edited by Hardman JG, Limbard LE. New York: McGraw Hill; 2001:569–619.

    Google Scholar 

  51. Planas ME, Rodriquez L, Sanchez S, et al.: Pharmacologic evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain 1995, 60:67–71.

    Article  PubMed  CAS  Google Scholar 

  52. Williamson DJ, Shepheard SL, Cook DA, et al.: Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurons in anesthetized rats. Br J Pharmacol 2001, 133:807–814.

    Article  PubMed  CAS  Google Scholar 

  53. Arner S, Meyerson BA: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988, 33:11–23.

    Article  PubMed  CAS  Google Scholar 

  54. Benedetti F, Vighetti S, Amanzio M, et al.: Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 1998, 74:205–211.

    Article  PubMed  CAS  Google Scholar 

  55. Attal N, Guirimand F, Brasseur L, et al.: Effects of IV morphine in central pain. Neurology 2002, 58:554–563.

    PubMed  CAS  Google Scholar 

  56. Ossipov MH, Lopez Y, Nichols ML, et al.: The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett 1995, 199:87–90.

    Article  PubMed  CAS  Google Scholar 

  57. Dellemijn P: Are opioids effective in relieving neuropathic pain? Pain 1999, 80:453–462.

    Article  PubMed  CAS  Google Scholar 

  58. Rowbotham MC, Reisner-Keller LA, Fields HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991, 41:1024–1028.

    PubMed  CAS  Google Scholar 

  59. Portnoy RK, Hagen NA: Breakthrough pain: definition, prevalence, and characteristics. Pain 1990, 41:273–281.

    Article  Google Scholar 

  60. Mao J, Price DD, Mayer DJ: Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994, 14:2301–2312.

    PubMed  CAS  Google Scholar 

  61. Celerier E, Laulin JP, Corcuff JB, et al.: Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci 2001, 21:4074–4080.

    PubMed  CAS  Google Scholar 

  62. Devulder J: Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain. J Neurosurg Anesthesiol 1997, 9:146–148.

    PubMed  CAS  Google Scholar 

  63. Sjogren P, Josson T, Jesen NH, et al.: Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993, 55:93–97.

    Article  PubMed  CAS  Google Scholar 

  64. Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:754–762.

    PubMed  CAS  Google Scholar 

  65. Carleton SC, Shesser RF, Pietrzak MP, et al.: Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med 1998, 32:129–138.

    Article  PubMed  CAS  Google Scholar 

  66. Larkin GL, Prescott JE: A randomized, double-blind comparative study of the efficacy of ketorolac tromethanine versus meperidine in the treatment of severe migraine. Ann Emerg Med 1992, 21:919–924.

    Article  PubMed  CAS  Google Scholar 

  67. Sicuteri F: Opioid receptor impairment underlying mechanism in “pain diseases”? Cephalalgia 1981, 1:77–82.

    Article  PubMed  CAS  Google Scholar 

  68. Panconesi A, Anselmi B, Franchi G: Increased adverse effects of opiates in migraine patients. Cephalalgia 1995, 15:159–160.

    PubMed  CAS  Google Scholar 

  69. Pini LA, Sandrini M, Vitale G: The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 1996, 308:31–40.

    Article  PubMed  CAS  Google Scholar 

  70. Bjorkman R: Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol: experimental studies in the rat. Acta Anaesthesiol Scand 1995, 39(suppl 103):1–44.

    Google Scholar 

  71. Srikiatkhachorn A, Anthony M: Platelet serotonin in patients with analgesic induced headache. Cephalalgia 1996, 16:423–426.

    Article  PubMed  CAS  Google Scholar 

  72. Srikiatkhachorn A, Manseesri S, Govitrapong P, et al.: Derangement of serotonin system in migraine patients with analgesic abuse headache: clues from the platelets. Headache 1998, 38:43–49.

    Article  PubMed  CAS  Google Scholar 

  73. Hering R, Glover V, Pattichis K, et al.: 5HT in migraine patients with medication-induced headaches. Cephalalgia 1993, 13:410–412.

    Article  PubMed  CAS  Google Scholar 

  74. Sarchelli P, Alberti A, Russo S, et al.: Nitric oxide pathway, Ca2+ and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia 1999, 19:810–816.

    Article  Google Scholar 

  75. Srikiatkhachorn A, Anuntasethakul T, Manseesri S, et al.: Hyposerotonin-induced nitric oxide supersensitivity in the cerebral microcirculation. Headache 2000, 40:267–275.

    Article  PubMed  CAS  Google Scholar 

  76. Srikiatkhachorn A, Tarasub N, Govitrapong P: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000, 40:343–350. This paper from a productive group of researchers in the field of headache significantly adds to our understanding of a potential mechanism for analgesic-induced headaches.

    Article  PubMed  CAS  Google Scholar 

  77. Carruba MO, Nisoli E, Garosi V, et al.: Catecholamine and serotonin depletion from rat spinal cord: effects on morphine and footshock-induced analgesia. Pharmacol Res 1992, 25:187–194.

    Article  PubMed  CAS  Google Scholar 

  78. Martinez F, Castillo J, Pardo J, et al.: Catecholamine levels in plasma and CSF in migraine. J Neurol Neurosurg Psychiatry 1993, 56:1119–1121.

    Article  PubMed  CAS  Google Scholar 

  79. Jhamandas KH, Powell KJ, Quirion R, et al.: Opioid tolerance and physical dependence: role of spinal neuropeptides, excitatory amino acids, and their messengers. Pain Res Manage 2000, 5:25–32.

    Google Scholar 

  80. Chen L, Huang LYM: Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu-opioid. Neuron 1991, 7:319–326.

    Article  PubMed  Google Scholar 

  81. Mao J, Mayer DJ: Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathologic pain. Ann NY Acad Sci 2001, 933:175–184. This is an insightful review of the cellular and intracellular mechanisms resulting in neural plasticity as it relates to neuropathic pain and the chronic administration of opioid analgesics.

    Article  PubMed  CAS  Google Scholar 

  82. Trang T, Sutak M, Quirion R, et al.: The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br J Pharmacol 2002, 136:37–48.

    Article  PubMed  CAS  Google Scholar 

  83. Mao J, Sung B, Ji R, et al.: Chronic morphine induces down regulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002, 22:8312–8323.

    PubMed  CAS  Google Scholar 

  84. Ozawa T, Nakagawa T, Shige K, et al.: Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res 2001, 905:254–258.

    Article  PubMed  CAS  Google Scholar 

  85. He L, Fong J, VonZastrow M, et al.: Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 2002, 108:271–282.

    Article  PubMed  CAS  Google Scholar 

  86. Machelska H, Ziolkowska B, Mika J, et al.: Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord. Neuroreport 1997, 8:2743–2747.

    Article  PubMed  CAS  Google Scholar 

  87. Przewlocki R, Przewlocka B: Opioids in chronic pain. Eur J Pharmacol 2001, 429:79–91.

    Article  PubMed  CAS  Google Scholar 

  88. Kieffer BL, Evans CJ: Opioid tolerance-in search of the Holy Grail. Cell 2002, 108:587–590.

    Article  PubMed  CAS  Google Scholar 

  89. Mao J, Price DD, Mayer DJ: Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and hyperalgesia. Pain 1995, 61:353–364.

    Article  PubMed  CAS  Google Scholar 

  90. Mao J, Sung B, Ru-Rong J, et al.: Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002, 22:7650–7661. This is a report of neuronal injury and apoptosis induced by chronic opioid administration and regulated through N-methyl-D-aspartate receptor activation in an animal model. The investigators speculate that this finding may contribute to an improved understanding of opioid pharmacology and the potential consequences of chronic opioid therapy and substance abuse.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Spaulding Rehabilitation Hospital, 125 Nashua Street, 02114, Boston, MA, USA

    David M. Biondi DO

Authors
  1. David M. Biondi DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biondi, D.M. Opioid resistance in chronic daily headache: A synthesis of ideas from the bench and bedside. Current Science Inc 7, 67–75 (2003). https://doi.org/10.1007/s11916-003-0013-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-003-0013-5

Keywords

Search

Navigation